Yin Chuan, Hemstedt Jenny, Scheuer Karl, Struczyńska Maja, Weber Christine, Schubert Ulrich S, Bossert Jörg, Jandt Klaus D
Chair of Material Science (CMS), Otto Schott Institute for Materials Research (OSIM), Friedrich Schiller University Jena, Löbdergraben 32, 07743 Jena, Germany.
Jena School for Microbial Communication (JSMC), Neugasse 23, 07743 Jena, Germany.
Nanomaterials (Basel). 2024 Feb 28;14(5):440. doi: 10.3390/nano14050440.
Polymeric nanoparticles (PNPs) are frequently researched and used in drug delivery. The degradation of PNPs is highly dependent on various properties, such as polymer chemical structure, size, crystallinity, and melting temperature. Hence, a precise understanding of PNP degradation behavior is essential for optimizing the system. This study focused on enzymatic hydrolysis as a degradation mechanism by investigation of the degradation of PNP with various crystallinities. The aliphatic polyester polylactide ([CHO]n, PLA) was used as two chiral forms, poly l-lactide (PlLA) and poly d-lactide (PdLA), and formed a unique crystalline stereocomplex (SC). PNPs were prepared via a nanoprecipitation method. In order to further control the crystallinity and melting temperatures of the SC, the polymer poly(3-ethylglycolide) [CHO]n (PEtGly) was synthesized. Our investigation shows that the PNP degradation can be controlled by various chemical structures, crystallinity and stereocomplexation. The influence of proteinase K on PNP degradation was also discussed in this research. AFM did not reveal any changes within the first 24 h but indicated accelerated degradation after 7 days when higher EtGly content was present, implying that lower crystallinity renders the particles more susceptible to hydrolysis. QCM-D exhibited reduced enzyme adsorption and a slower degradation rate in SC-PNPs with lower EtGly contents and higher crystallinities. A more in-depth analysis of the degradation process unveiled that QCM-D detected rapid degradation from the outset, whereas AFM exhibited delayed changes of degradation. The knowledge gained in this work is useful for the design and creation of advanced PNPs with enhanced structures and properties.
聚合物纳米颗粒(PNPs)在药物递送领域得到了广泛的研究与应用。PNPs的降解高度依赖于多种性质,如聚合物化学结构、尺寸、结晶度和熔点。因此,精确了解PNP的降解行为对于优化该系统至关重要。本研究通过考察不同结晶度的PNP的降解情况,重点关注酶促水解作为一种降解机制。脂肪族聚酯聚丙交酯([CHO]n,PLA)以两种手性形式使用,即聚L-丙交酯(PlLA)和聚D-丙交酯(PdLA),并形成了独特的结晶立体复合物(SC)。PNPs通过纳米沉淀法制备。为了进一步控制SC的结晶度和熔点,合成了聚合物聚(3-乙基乙交酯)[CHO]n(PEtGly)。我们的研究表明,PNP的降解可以通过各种化学结构、结晶度和立体复合作用来控制。本研究还讨论了蛋白酶K对PNP降解的影响。原子力显微镜(AFM)在前24小时内未发现任何变化,但表明当EtGly含量较高时,7天后降解加速,这意味着较低的结晶度使颗粒更容易水解。石英晶体微天平耗散技术(QCM-D)显示,在EtGly含量较低且结晶度较高的SC-PNPs中,酶吸附减少,降解速率较慢。对降解过程的更深入分析表明,QCM-D从一开始就检测到快速降解,而AFM则显示出降解的延迟变化。这项工作中获得的知识有助于设计和创建具有增强结构和性能的先进PNPs。